Q-Linea
0,042
SEK
-6,53 %
Mindre end 1K følgere
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Finansielt overblik og estimater
Ownership
-6,53%
-90,19%
-57,49%
-75,96%
-91,24%
-86,79%
-99,63%
-99,55%
-99,56%
Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.
Læs mereMarkedsværdi
184,6 mio. SEK
Aktieomsætning
3,3 mio. SEK
Omsætning
2,36 mio.
EBIT %
-9.052,54 %
P/E
-
Udbytteafkast, %
-
Finanskalender
3.4
2025
Ekstraordinær generalforsamling '25
29.4
2025
Delårsrapport Q1'25
26.6
2025
Generalforsamling '25
ViserAlle indholdstyper
Q-linea announces the initiation of another US ASTar evaluation
Redeye: Q-linea Q4 - Several commercial steps in the right direction
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools